Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Lessons Learned from a Clinical Trial Failure
Posted on March 14th, 2017 by Prima Sung in Chemistry
Revisiting failed clinical trials is important because these studies may generate new insights into drug research and development, leading to effective new treatments. Researchers in the recent IMPROVE-IT trial learned valuable lessons from the failure of the earlier ENHANCE study (more…)
A Small Change with Big Implications for Alzheimer’s Research
Posted on October 14th, 2016 by Patrick C. May, PH.D. in Pharma R&D
Many an undergrad biochemistry student is challenged to remember the difference between the amino acids valine and isoleucine. They differ by a single methyl group in their side chains (more…)
The New Clinical Trial Directive, Low Risk Intervention Clinical Trials and Pharmacovigilance Reporting Adjustments
Posted on October 3rd, 2016 by J.-P. Clement MD in Pharmacovigilance
The new Clinical Trial Directive (EU 536/2014), is applicable since May 2016 with a transition period of three years (May 2019) for CT applications submitted before that date. (more…)
Women and minorities in clinical trials
Posted on September 16th, 2016 by Jeffrey Paul, PhD in Pharma R&D
You are a female and/or a minority and concerned if you will respond to your medication. So you read the product label, asking yourself, “Do I see myself described as a patient in the drug testing trials?” (more…)
